167 related articles for article (PubMed ID: 25719478)
1. Molecular characterisation of clinical and environmental isolates of Mycobacterium kansasii isolates from South African gold mines.
Kwenda G; Churchyard GJ; Thorrold C; Heron I; Stevenson K; Duse AG; Marais E
J Water Health; 2015 Mar; 13(1):190-202. PubMed ID: 25719478
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology.
Corbett EL; Hay M; Churchyard GJ; Herselman P; Clayton T; Williams BG; Hayes R; Mulder D; De Cock KM
Int J Tuberc Lung Dis; 1999 Jun; 3(6):501-7. PubMed ID: 10383063
[TBL] [Abstract][Full Text] [Related]
3. Strain variation amongst clinical and potable water isolates of M. kansasii using automated repetitive unit PCR.
Thomson R; Tolson C; Huygens F; Hargreaves M
Int J Med Microbiol; 2014 May; 304(3-4):484-9. PubMed ID: 24636860
[TBL] [Abstract][Full Text] [Related]
4. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners.
Corbett EL; Blumberg L; Churchyard GJ; Moloi N; Mallory K; Clayton T; Williams BG; Chaisson RE; Hayes RJ; De Cock KM
Am J Respir Crit Care Med; 1999 Jul; 160(1):15-21. PubMed ID: 10390374
[TBL] [Abstract][Full Text] [Related]
5. hsp65 PCR-restriction analysis (PRA) with capillary electrophoresis for species identification and differentiation of Mycobacterium kansasii and Mycobacterium chelonae-Mycobacterium abscessus group.
Sajduda A; Martin A; Portaels F; Palomino JC
Int J Infect Dis; 2012 Mar; 16(3):e193-7. PubMed ID: 22240012
[TBL] [Abstract][Full Text] [Related]
6. Short communication: subtyping of Mycobacterium kansasii by PCR-restriction enzyme analysis of the hsp65 gene.
Bakuła Z; Safianowska A; Nowacka-Mazurek M; Bielecki J; Jagielski T
Biomed Res Int; 2013; 2013():178725. PubMed ID: 24455675
[TBL] [Abstract][Full Text] [Related]
7. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners.
Corbett EL; Churchyard GJ; Hay M; Herselman P; Clayton T; Williams B; Hayes R; Mulder D; De Cock KM
Am J Respir Crit Care Med; 1999 Jul; 160(1):10-4. PubMed ID: 10390373
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
da Silva Telles MA; Chimara E; Ferrazoli L; Riley LW
J Med Microbiol; 2005 Oct; 54(Pt 10):975-979. PubMed ID: 16157553
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of Mycobacterium kansasii isolates in the State of São Paulo between 1995-1998.
Chimara E; Giampaglia CM; Martins MC; Telles MA; Ueki SY; Ferrazoli L
Mem Inst Oswaldo Cruz; 2004 Nov; 99(7):739-43. PubMed ID: 15654431
[TBL] [Abstract][Full Text] [Related]
10. [Present status of studies on epidemiology and molecular epidemiology of Mycobacterium kansasii, in special reference to its molecular epidemiology].
Yoshida S; Saito H; Suzuki K
Kekkaku; 2011 Jul; 86(7):681-4. PubMed ID: 21922776
[TBL] [Abstract][Full Text] [Related]
11. [Molecular epidemiological analysis of Mycobacterium kansasii isolates].
Yoshida S; Suzuki K; Tsuyuguchi K; Iwamoto T; Okada M; Sakatani M
Kekkaku; 2007 Feb; 82(2):103-10. PubMed ID: 17373319
[TBL] [Abstract][Full Text] [Related]
12. ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii.
Arend SM; de Haas P; Leyten E; Rosenkrands I; Rigouts L; Andersen P; Mijs W; van Dissel JT; van Soolingen D
J Infect Dis; 2005 Apr; 191(8):1301-10. PubMed ID: 15776377
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China.
Guo Y; Cao Y; Liu H; Yang J; Wang W; Wang B; Li M; Yu F
Microbiol Spectr; 2022 Feb; 10(1):e0147521. PubMed ID: 35019778
[TBL] [Abstract][Full Text] [Related]
14. Human pathogenic
Fukano H; Terazono T; Hirabayashi A; Yoshida M; Suzuki M; Wada S; Ishii N; Hoshino Y
Emerg Microbes Infect; 2021 Dec; 10(1):220-222. PubMed ID: 33467980
[TBL] [Abstract][Full Text] [Related]
15. [PFGE analysis of Mycobacterium kansasii isolates in Okayama Prefecture].
Mimura K
Kekkaku; 2005 Feb; 80(2):63-8. PubMed ID: 15920977
[TBL] [Abstract][Full Text] [Related]
16. Whole genome sequence of Mycobacterium kansasii isolates of the genotype 1 from Brazilian patients with pulmonary disease demonstrates considerable heterogeneity.
Machado E; Vasconcellos SEG; Cerdeira C; Gomes LL; Junqueira R; Carvalho LD; Ramos JP; Redner P; Campos CED; Caldas PCS; Gomes APCS; Goldenberg T; Montes FF; Mello FCQ; Mussi VO; Lasunskaia E; Soolingen DV; Miranda AB; Rigouts L; Jong BC; Meehan CJ; Catanho M; Suffys PN
Mem Inst Oswaldo Cruz; 2018 Jun; 113(9):e180085. PubMed ID: 29947722
[TBL] [Abstract][Full Text] [Related]
17. Phylogenomics reveal that Mycobacterium kansasii subtypes are species-level lineages. Description of Mycobacterium pseudokansasii sp. nov., Mycobacterium innocens sp. nov. and Mycobacterium attenuatum sp. nov.
Tagini F; Aeby S; Bertelli C; Droz S; Casanova C; Prod'hom G; Jaton K; Greub G
Int J Syst Evol Microbiol; 2019 Jun; 69(6):1696-1704. PubMed ID: 30950782
[TBL] [Abstract][Full Text] [Related]
18. [Non-tuberculous mycobacteriosis. What has been coming out].
Kajiki A
Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of two typing methods, hsp65 PRA and ITS sequencing, revealed a possible evolutionary link between Mycobacterium kansasii type I and II isolates.
Iwamoto T; Saito H
FEMS Microbiol Lett; 2006 Jan; 254(1):129-33. PubMed ID: 16451190
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenicity of Mycobacterium kansasii].
Vesenbeckh S; Wagner S; Mauch H; Roth A; Streubel A; Rüssmann H; Bauer TT; Matthiessen W; Schönfeld N
Pneumologie; 2014 Aug; 68(8):526-31. PubMed ID: 25046682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
